Althea offers cGMP plasmid production, protein production, formulation and filling services. Plasmid DNA and protein production are offered using both Althea’s industry-leading manufacturing process as well as client developed processes. A range of options are available for formulation and filling services ranging from semi- automated to fully- automated processes for vials and syringes. Althea is focused on offering highly responsive customer service, flexible scheduling, and rapid turnaround times to meet the requirements of both early stage clinical programs and commercial programs alike.
Althea Technologies Receives Two Fast Growth Awards: Deloitte & Touche and San Diego Business Journal for the Fourth Consecutive Year
SAN DIEGO – October 17, 2007 -- Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that it has been honored to receive two fast growth awards, Deloitte & Touche’s San Diego Technology Fast 50 and the San Diego Business Journal 100 Fastest Growing Private Companies, each for the fourth consecutive year. Deloitte annually recognizes the 50 fastest growing technology companies based on a percentage revenue growth over a five year period, while San Diego Business Journal looks at revenue growth over three years.
Althea’s year-on-year revenue growth has been driven primarily by its manufacturing services supporting new biopharmaceutical developers, who require specialized facilities and expertise to manufacture their products. Selection for Deloitte & Touche was based on percentage revenue growth over five years from 2002 to 2006, an established headquarters in San Diego and ownership of proprietary technology or intellectual property, which contributes to a significant portion of its operating revenues.
The San Diego Business Journal selection process included percent revenue growth achieved from 2004 to 2006, required that the company be privately held, based in San Diego County and have a minimum revenue of $200,000 in 2004 in order to be considered for the list.
President and Co-CEO of Althea, Dr. Magda Marquet, added, “Being honored with Deloitte’s Fast 50 award and the San Diego Business Journal’s Fast 100 award for the fourth year is a great affirmation of Althea’s success continuing to meet the demands of the pharmaceutical and biotechnology industry’s needs for flexible and compliant services. Althea’s growth is directly linked not just to our solid customer base and innovative technology, but also to the contributions of our dedicated employees.”
About Althea Technologies, Inc.
Althea Technologies, a leading San Diego-based pharmaceutical services firm, provides critical manufacturing and development services that support researchers worldwide in their advancement of novel therapies and efforts to apply new genomic information. Althea’s services include cGMP contract manufacturing of recombinant proteins, DNA-based therapeutics and vaccines, aseptic filling, and gene quantification using real-time PCR and gene expression analysis under GLP conditions. Additionally, Althea has introduced new services and technologies for the identification and development of genetic biomarkers with innovative programs such as the company’s proprietary Express Pathway℠. For more information, visit www.altheatech.com.About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other’s acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte," "Deloitte & Touche," "Deloitte Touche Tohmatsu," or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein. Deloitte & Touche USA LLP is the U.S. member firm of Deloitte Touche Tohmatsu. In the U.S., services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP. For more information, please visit the U.S. member firm’s Web site at www.deloitte.com.About The San Diego Business Journal
The San Diego Business Journal is the area’s number one source for local, late breaking business news. For over 27 years, the Business Journal has provided in-depth coverage of the banking and finance, real estate, technology, tourism, life sciences and local government sectors, with a healthy dose of small business coverage as well. This has allowed the 48,000 readers to become incredibly well informed and assisted in taking their own business to the top of their respective sectors. For more information please visit www.sdbj.com.Contact:
| Althea Technologies, Inc. John E. H. Cox Marketing Project Manager (858) 882-0201 jcox@altheatech.com |
Althea Technologies
A leading provider of contract services to
the pharmaceutical and biotechnology industries
11040 Roselle Street | San Diego, CA 92121-1205
Toll-free 1-888-4ALTHEA
info@altheatech.com